Philips eCare Platform Gets FDA Approval

Royal Philips has announced that its eCareCoordinator and eCareCompanion telehealth apps have received 510(k) clearance from the U.S. Food and Drug Administration.


Royal Philips has announced that its eCareCoordinator and eCareCompanion telehealth apps have received 510(k) clearance from the U.S. Food and Drug Administration.

A part of Philips Hospital to Home’s suite of telehealth programs, eCareCoordinator and eCareCompanion are focused on patient care within the home and are the first clinical apps to be available through the cloud-based digital health platform, which Philips announced in collaboration with salesforce.com earlier in 2014.

eCareCoordinator supports population health management by providing clinicians with a daily review of each of their patients, allowing them to prioritize patients and adjust care plans or intervene as needed. The app gives clinicians real-time access to both objective health data--like vital signs, blood pressure and weight--as well as subjective responses collected via health questionnaires and other communication with the care team about the patient’s status.

The eCareCompanion app serves as the patient portal, accessed via a tablet, and allows patients to answer questions about their health and enter requested measurements to stay connected with their care teams. The app also proactively reminds them of pre-assigned health tasks, like taking medications, to encourage adherence and better outcomes. Philips executives said its ability to connect with medical devices, such as a weight scale, oximeter, blood pressure meter, and medicine dispenser, enables a deeper insight into patient health.

The two apps will support new at-home care models like the program being piloted at Phoenix-based Banner Health, a pioneer accountable care organization. Philips will be launching a similar program with Henry Ford Health System in Detroit.